Affitech Research As
Records under this name other than patents Affitech Research As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,394,943 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,034,905 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,340,609 | Antibodies Against Human Angiopoietin 2 Formerly held In force · High confidence | In force | High confidence | |
| US 8,133,979 | Antibodies Against Human Angiopoietin 2 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,073,986 | Antibodies Against Human Angiopoietin 2 Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,421,256 | Anti-VEGF antibody compositions and methods Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,969,253 | Method For Screening Phage Display Libraries Against Each Other Formerly held In force · High confidence | In force | High confidence | |
| US 9,145,461 | Antibodies Formerly held Lapsed on the fee record Ended Sep 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 29, 2023 | From the USPTO record |
| US 10,266,599 | Antibodies which bind to the human CC chemokine receptor 4 and uses thereof Formerly held Lapsed on the fee record Ended Apr 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2023 | From the USPTO record |
| US 8,895,007 | Antibodies which bind to the human CC chemokine receptor 4 and uses thereof Formerly held Lapsed on the fee record Ended Nov 25, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 25, 2022 | From the USPTO record |